BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33131302)

  • 1. Use of Artificial Intelligence Deep Learning to Determine the Malignant Potential of Pancreatic Cystic Neoplasms With Preoperative Computed Tomography Imaging.
    Watson MD; Lyman WB; Passeri MJ; Murphy KJ; Sarantou JP; Iannitti DA; Martinie JB; Vrochides D; Baker EH
    Am Surg; 2021 Apr; 87(4):602-607. PubMed ID: 33131302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients.
    Park RHS; Lim GRS; Wu JJY; Koh YX; Teo JY; Cheow PC; Chan CY; Ooi LLPJ; Chung AYF; Goh BKP
    Eur J Surg Oncol; 2020 Nov; 46(11):2114-2121. PubMed ID: 32828582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.
    Kaimakliotis P; Riff B; Pourmand K; Chandrasekhara V; Furth EE; Siegelman ES; Drebin J; Vollmer CM; Kochman ML; Ginsberg GG; Ahmad NA
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1808-15. PubMed ID: 25818077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.
    Liu K; Joshi V; van Camp L; Yang QW; Baars JE; Strasser SI; McCaughan GW; Majumdar A; Saxena P; Kaffes AJ
    World J Gastroenterol; 2017 Dec; 23(48):8526-8532. PubMed ID: 29358860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Sendai and Fukuoka consensus guidelines in predicting malignancy in patients with preoperatively diagnosed mucinous pancreatic cystic neoplasms.
    Zhou W; Xu Y; Rong Y; Wu W; Kuang T; Xin B; Zhu H; Lou W; Wang D
    J Surg Oncol; 2018 Mar; 117(3):409-416. PubMed ID: 29044541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of malignancy in pancreatic cysts with cytology of high-grade epithelial atypia.
    Hoda RS; Lu R; Arpin RN; Rosenbaum MW; Pitman MB
    Cancer Cytopathol; 2018 Sep; 126(9):773-781. PubMed ID: 30257067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Sendai and 2012 International Consensus Guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patients.
    Goh BK; Thng CH; Tan DM; Low AS; Wong JS; Cheow PC; Chow PK; Chung AY; Wong WK; Ooi LL
    Am J Surg; 2014 Aug; 208(2):202-9. PubMed ID: 24530043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
    Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
    Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
    Pedrazzoli S; Sperti C; Pasquali C; Bissoli S; Chierichetti F
    Ann Surg; 2011 Dec; 254(6):971-6. PubMed ID: 22076067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
    Roch AM; Barron MR; Tann M; Sandrasegar K; Hannaford KN; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2015 Jul; 221(1):48-56. PubMed ID: 26095551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
    Raman SP; Kawamoto S; Blackford A; Hruban RH; Lennon AM; Wolfgang CL; Rezaee N; Edil B; Fishman EK
    AJR Am J Roentgenol; 2013 Mar; 200(3):563-9. PubMed ID: 23436845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms.
    Permuth JB; Choi J; Balarunathan Y; Kim J; Chen DT; Chen L; Orcutt S; Doepker MP; Gage K; Zhang G; Latifi K; Hoffe S; Jiang K; Coppola D; Centeno BA; Magliocco A; Li Q; Trevino J; Merchant N; Gillies R; Malafa M;
    Oncotarget; 2016 Dec; 7(52):85785-85797. PubMed ID: 27589689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate prediction of histological grading of intraductal papillary mucinous neoplasia using deep learning.
    Schulz D; Heilmaier M; Phillip V; Treiber M; Mayr U; Lahmer T; Mueller J; Demir IE; Friess H; Reichert M; Schmid RM; Abdelhafez M
    Endoscopy; 2023 May; 55(5):415-422. PubMed ID: 36323331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012: a retrospective review.
    Watanabe Y; Nishihara K; Niina Y; Abe Y; Amaike T; Kibe S; Mizuuchi Y; Kakihara D; Ono M; Tamiya S; Toyoshima S; Nakano T; Mitsuyama S
    Surg Today; 2016 Sep; 46(9):1045-52. PubMed ID: 26689209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients.
    Goh BK; Tan DM; Thng CH; Lee SY; Low AS; Chan CY; Wong JS; Lee VT; Cheow PC; Chow PK; Chung AY; Wong WK; Ooi LL
    Ann Surg Oncol; 2014 Jun; 21(6):1919-26. PubMed ID: 24504924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced endoscopic ultrasound diagnosis of the intraductal papillary mucinous neoplasm.
    Del Vecchio Blanco G; Gesuale C; Anselmo A; Palmieri G; Baciorri F; Di Prete M; Tisone G; Monteleone G; Paoluzi OA
    Clin J Gastroenterol; 2020 Feb; 13(1):120-126. PubMed ID: 31280471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Kuwahara T; Hara K; Mizuno N; Okuno N; Matsumoto S; Obata M; Kurita Y; Koda H; Toriyama K; Onishi S; Ishihara M; Tanaka T; Tajika M; Niwa Y
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31117111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
    Srinivasan N; Koh YX; Goh BKP
    Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up.
    Schellhaas B; Vitali F; Wildner D; Görtz RS; Pfeifer L; Konturek PC; Neurath MF; Strobel D
    Med Sci Monit; 2017 Mar; 23():1483-1492. PubMed ID: 28348359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.